Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Dalfelt Clinical Trials Consultancy AB
AB
Active
Org 5590970504
Mäster Olofs Väg 4
Business and other management consultancy activities · NACE 7020
Est. 2017
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 2,9M
-21% vs 2023
EBITDA margin
94.4%
-23% vs 2023
Equity ratio
67.4%
Financial strength
Net profit 2024
SEK 1,8M
-12% vs 2023
EBITDA — year on year
SEK millions
5M
4M
3M
1M
0M
3M
2020
4M
+33%
2021
4M
0%
2022
4M
0%
2023
3M
-25%
2024
Key figures
Annual report 2024
Revenue
SEK 2,9M
-21%
EBITDA
SEK 2,8M
-23%
Net profit
SEK 1,8M
-12%
Total assets
SEK 16,2M
+21%
Equity
SEK 10,9M
+20%
Employees
1
—
Company information
Legal name
Dalfelt Clinical Trials Consultancy AB
Org number
5590970504
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
12 januari 2017
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva konsultverksamhet inom, och undervisning i, läkemedelsutveckling.
Contact
Address
Mäster Olofs Väg 4
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Business and other management consultancy activities
Companies in Lund
All Sweden companies
Revenue
SEK millions
0M
1M
2M
3M
5M
4M
2020
4M
2021
4M
2022
4M
2023
3M
2024
EBITDA
SEK millions
0M
1M
2M
3M
5M
3M
2020
4M
2021
4M
2022
4M
2023
3M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
3 506
4 177
3 875
3 691
2 926
Staff expenses
—
—
−4
−15
−9
EBITDA
3 126
4 061
3 743
3 567
2 762
Depreciation & amort.
−0
−0
—
—
—
EBIT
3 126
4 061
3 743
3 567
2 762
Net financials
—
—
0
2
377
Profit before tax
2 344
3 044
2 801
2 660
2 341
Tax
−502
−654
−582
−562
−503
Net profit
1 842
2 390
2 219
2 098
1 838
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
3 997
8 164
10 865
13 409
16 176
Equity
2 360
4 750
6 969
9 067
10 905
Long-term debt
0
0
—
—
—
Short-term debt
655
1 413
954
490
621
Total debt
655
1 413
954
490
621
Financial ratios
5-year trend
EBITDA margin
94.4%
This company
15.8%
Market median
+497% vs market
2020
2024
Equity ratio
67.4%
This company
38.2%
Market median
+76% vs market
2020
2024
Return on equity
16.9%
This company
18.4%
Market median
+8% vs market
2020
2024
Net profit margin
62.8%
This company
8.1%
Market median
+675% vs market
2020
2024
Asset turnover
0.18×
This company
1.12×
Market median
-84% vs market
2020
2024
Debt / equity
0.48×
This company
0.62×
Market median
+23% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2019-07-01 – 2020-06-30
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
AF
Anders Filip Lundberg
Audit
Audit
2025
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
IA
Ingegerd Anne C Wedelfors Dalfelt
Board of Directors
2022
KG
Karl Göran Dalfelt
Deputy Board Member
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Dalfelt Clinical Trials Consultancy AB also hold positions in
0
other companies.
Person
Role here
Other companies
Anders Filip Lundberg
Audit
0 companies
Ingegerd Anne C Wedelfors Dalfelt
Board of Directors
0 companies
Karl Göran Dalfelt
Deputy Board Member
0 companies